This information was provided by prnewswire
Send your Press Release here.
TORONTO, Jan. 15, 2019 /CNW/ – Beleave Inc. (CSE: BE) (OTCQX: BLEVF) (“Beleave” or the “Company“) is excited to announce its wholly-owned subsidiary Beleave Kannabis Corp. has been authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.
“This license is pivotal to us meeting our goals in 2019, while driving product innovation and augmenting our research and development initiatives,” said Roger Ferreira, Ph.D., Beleave’s Chief Science Officer. “Oils will continue to make up a larger part of the cannabis market, especially as we ramp up for the regulatory changes coming in 2019. Receiving our sales authorization allows us to provide a wider array of products while providing Beleave with higher margins than dried flower.”
Leave a Reply